GlassScriptPhysician profile
Amy D Dillon
NPI 1386614089
$3,318.20
in general payments reported to CMS, 2019-2025
19 companies · $619 in 2025
The $619 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $731 · 2022: $641 · 2023: $613 · 2024: $713 · 2025: $619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,945.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $637.68 | 2021-2025 | |
| Abbvie INC. | $582.43 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $501.46 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $318.09 | 2021-2025 | Zerbaxa, Verquvo, Dificid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $291.88 | 2021-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $206.93 | 2023-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $171.43 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $119.53 | 2021-2024 | Lokelma |
| Gilead Sciences, INC. | $91.16 | 2021-2023 | Veklury |
| Novo Nordisk INC | $86.98 | 2023-2024 | Ozempic, Rybelsus |
| Alexion Pharmaceuticals, INC. | $76.27 | 2021-2023 | Ultomiris |
| Sk Life Science, INC. | $67.05 | 2025 | |
| Boston Scientific Corporation | $40.01 | 2021-2022 | |
| Philips North America LLC | $35.31 | 2022-2023 | |
| Paratek Pharmaceuticals, INC. | $24.34 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $19.44 | 2025 | Collagenase Santyl |
| Melinta Therapeutics, LLC | $17.80 | 2022 | |
| Electromed, INC. | $15.38 | 2023 | Smartvest |
| Corium, LLC | $15.03 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Dillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.